Literature DB >> 12106981

Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.

Sanjeeb K Sahoo1, Jayanth Panyam, Swayam Prabha, Vinod Labhasetwar.   

Abstract

Polyvinyl alcohol (PVA) is the most commonly used emulsifier in the formulation of poly lactide and poly (D,L-lactide-co-glycolide) (PLGA) polymeric nanoparticles. A fraction of PVA remains associated with the nanoparticles despite repeated washing because PVA forms an interconnected network with the polymer at the interface. The objective of this study was to determine the parameters that influence the amount of residual PVA associated with PLGA nanoparticles and its effect on the physical properties and cellular uptake of nanoparticles. Nanoparticles were formulated by a multiple emulsion-solvent evaporation technique using bovine serum albumin (BSA) as a model protein. The parameters that affected the amount of residual PVA include the concentration of PVA and the type of organic solvent used in the emulsion. The residual PVA, in turn, influenced different pharmaceutical properties of nanoparticles such as particle size, zeta potential, polydispersity index, surface hydrophobicity, protein loading and also slightly influenced the in vitro release of the encapsulated protein. Importantly, nanoparticles with higher amount of residual PVA had relatively lower cellular uptake despite their smaller particle size. It is proposed that the lower intracellular uptake of nanoparticles with higher amount of residual PVA could be related to the higher hydrophilicity of the nanoparticle surface. In conclusion, the residual PVA associated with nanoparticles is an important formulation parameter that can be used to modulate the pharmaceutical properties of PLGA nanoparticles. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106981     DOI: 10.1016/s0168-3659(02)00127-x

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  168 in total

1.  Biodegradable salicylate-based poly(anhydride-ester) microspheres for controlled insulin delivery.

Authors:  Roberto Delgado-Rivera; Roselin Rosario-Meléndez; Weiling Yu; Kathryn E Uhrich
Journal:  J Biomed Mater Res A       Date:  2013-09-24       Impact factor: 4.396

2.  Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).

Authors:  Chris Brough; Dave A Miller; Daniel Ellenberger; Dieter Lubda; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2016-02-10       Impact factor: 3.246

3.  Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions.

Authors:  Gautam Dalwadi; Heather A E Benson; Yan Chen
Journal:  Pharm Res       Date:  2005-12       Impact factor: 4.200

4.  Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy.

Authors:  Sinjan De; Dennis H Robinson
Journal:  AAPS PharmSciTech       Date:  2004-09-13       Impact factor: 3.246

Review 5.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

6.  The effect of PLGA sphere diameter on rabbit mesenchymal stem cells in adipose tissue engineering.

Authors:  Yu Suk Choi; Si-Nae Park; Hwal Suh
Journal:  J Mater Sci Mater Med       Date:  2007-11-28       Impact factor: 3.896

Review 7.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

8.  Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.

Authors:  Ming Yang; Samuel K Lai; Tao Yu; Ying-Ying Wang; Christina Happe; Weixi Zhong; Michael Zhang; Abraham Anonuevo; Colleen Fridley; Amy Hung; Jie Fu; Justin Hanes
Journal:  J Control Release       Date:  2014-07-29       Impact factor: 9.776

9.  Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

Authors:  Sara M Navarro; Caleb Darensbourg; Linda Cross; Rhett Stout; Diana Coulon; Carlos E Astete; Timothy Morgan; Cristina M Sabliov
Journal:  Ther Deliv       Date:  2014-11

10.  Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice.

Authors:  Maha Fadel; Kawser Kassab; Doa Abdel Fadeel
Journal:  Lasers Med Sci       Date:  2010-03       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.